The Daring Businessman of Hyderabad"'
From drawing a salary of Rs 400 as an accounts assistant in SOL to building a 740 crore company speaks volumes of this entrepreneur from Hyderabad. The hunger to be in business and become somebody in the pharmacy industry took him to Pondicherry in 1987 where he set up Arobindo Pharma with a few friends. In 1990 it got shifted to Hyderabad, and then onwards there has been no looking back .Aurobindo Pharma is poised to cross Rs 7250 million ($165 million) company with 7 manufacturing units in Andhra Pradesh, Pondicherry and other states in India .
Aurobindo Pharma has a well established marketing network in India and across the globe. Aurobindo Pharma enjoys the confidence of about 600 reputed formulators in India and about 200 customers in 70 countries serviced by the sales offices in Moscow, Miami, and Hongkong.The major customers of Aurobindo Pharma includes Ranbaxy Laboratories Ltd, Cipla Ltd, Dr. Reddy Labs Ltd, Lupin Labs Ltd, IPCA, Torrent Pharma Ltd, SPIC, Sarabhai, ALKEM Laboratories, TTK, Lyka Labs Citadel Smithkline Beecham, Glaxo, Indukern AG.Schwezer hall Borospvskig zavod etc.In an Investors survey, Aurobindo Pharma has totted up the highest returns compared to Multinationals such as Pfizer and Glaxo in the past three years. It moved up the value chain:from bulk drugs to formulations to generics.
May'00 marks the inauguration of Arobindo Pharma's Research centre which is fully geared up to meet the challenges and opportunities of post GATT era. This research centre located at Bachupally will have a highly experienced team of over 100 scientists who will work on advanced molecules meeting Internationl standards.
From drawing a salary of Rs 400 as an accounts assistant in SOL to building a 740 crore company speaks volumes of this entrepreneur from Hyderabad. The hunger to be in business and become somebody in the pharmacy industry took him to Pondicherry in 1987 where he set up Arobindo Pharma with a few friends. In 1990 it got shifted to Hyderabad, and then onwards there has been no looking back .Aurobindo Pharma is poised to cross Rs 7250 million ($165 million) company with 7 manufacturing units in Andhra Pradesh, Pondicherry and other states in India .
Aurobindo Pharma has a well established marketing network in India and across the globe. Aurobindo Pharma enjoys the confidence of about 600 reputed formulators in India and about 200 customers in 70 countries serviced by the sales offices in Moscow, Miami, and Hongkong.The major customers of Aurobindo Pharma includes Ranbaxy Laboratories Ltd, Cipla Ltd, Dr. Reddy Labs Ltd, Lupin Labs Ltd, IPCA, Torrent Pharma Ltd, SPIC, Sarabhai, ALKEM Laboratories, TTK, Lyka Labs Citadel Smithkline Beecham, Glaxo, Indukern AG.Schwezer hall Borospvskig zavod etc.In an Investors survey, Aurobindo Pharma has totted up the highest returns compared to Multinationals such as Pfizer and Glaxo in the past three years. It moved up the value chain:from bulk drugs to formulations to generics.
May'00 marks the inauguration of Arobindo Pharma's Research centre which is fully geared up to meet the challenges and opportunities of post GATT era. This research centre located at Bachupally will have a highly experienced team of over 100 scientists who will work on advanced molecules meeting Internationl standards.
0 comments:
Post a Comment